AstraZeneca Pharma India Limited, a biopharmaceutical company, is engaged in the manufacturing, distribution, and marketing of pharmaceutical products in both India and international markets. The company specializes in the production and sale of medications for cardiovascular disease and diabetes, which are marketed under various brand names such as Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN. Additionally, AstraZeneca Pharma India Limited offers respiratory medications under the brand names Symbicort and FASENRA, as well as oncology medications under the brands LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex. The company also provides products in the fields of renal, metabolic, and immunology diseases, and offers clinical trial services. Established in 1979, AstraZeneca Pharma India Limited is headquartered in Bengaluru, India, and operates as a subsidiary of AstraZeneca Pharmaceuticals AB.
AstraZeneca Pharma India Limited
- 6,868.10 -52.20(-0.75%) 6,858.40 -55.55(-0.80%)
Live AstraZeneca Pharma India Limited Share Price Chart
AstraZeneca Pharma India Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 6,786.65 6,791.05 | 6,898.15 6920.30 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 4,785.00 (14-Mar-2024) 4,050.15 (21-Mar-2024) | 8,139.00 (07-Oct-2024) 8,139.85 (30-Sep-2024) |
- Open
- 6,865.65 6,920.30
- Previous Close
- 6,920.30 6,913.95
- Volume
- 0.05
- Total Traded value
- 3.63 (Lakhs)
- Upper circuit
- 8,304.35 7,489.05
- Lower circuit
- 5,536.25 4,992.75
AstraZeneca Pharma India Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 2,815 | 3,052 |
| Bid Price | Quantity |
|---|---|
| 6,862.85 | 3.00 |
| 6,862.80 | 1.00 |
| 6,862.75 | 1.00 |
| 6,862.70 | 2.00 |
| 6,862.65 | 1.00 |
| Total: | 2,815 |
| Ask Price | Quantity |
|---|---|
| 6,876.10 | 1.00 |
| 6,876.75 | 2.00 |
| 6,877.40 | 1.00 |
| 6,877.45 | 1.00 |
| 6,877.55 | 1.00 |
| Total: | 3,052 |
AstraZeneca Pharma India Limited Share Fundamentals
| Market Cap: | 171.70 Cr |
| PE Ratio (TTM): | 209.29 |
| PB Ratio: | 25.24 |
| Industry P/E: | 95.94 |
| Debt to Equity: | - |
| ROE: | 12.06 |
| EPS (TTM): | 32.77 |
| Book Value: | 261.99 |
| Face Value: | 2.00 |
AstraZeneca Pharma India Limited Stock Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 311.07 Cr | 295.47 Cr | 284.70 Cr | 249.81 Cr | 236.13 Cr |
| Profit | 52.37 Cr | 53.86 Cr | 17.27 Cr | 29.30 Cr | 32.56 Cr |
| Expense | 262.49 Cr | 232.17 Cr | 229.19 Cr | 217.55 Cr | 198.85 Cr |
| Comprehensive income | 52.66 Cr | 54.32 Cr | 15.19 Cr | 29.03 Cr | 32.38 Cr |
| EPS | 20.95 | 21.54 | 6.91 | 11.72 | 13.03 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| AstraZeneca Pharma India Limited | May, 2001 Aug, 1982 | Pharmaceuticals Pharmaceuticals | ASTRAZEN ASTRAZEN |
AstraZeneca Pharma India Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
AstraZeneca Pharma India Limited Share FAQ's
What is the range of today's stock performance for AstraZeneca Pharma India Limited?
Today's stock performance witnessed a fluctuation from a minimum of 6,786.65 on the NSE (National Stock Exchange) to a maximum of 6,898.15. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 6,791.05 to a high of 6,920.30.
What are the 52-week low and high values for AstraZeneca Pharma India Limited?
The stock's performance over the past 52 weeks reveals a low of 4,785.00 (occurred on 14-Mar-2024) and a high of 8,139.00 (achieved on 07-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,050.15 (on 21-Mar-2024), and the 52-week high is 8,139.85 (on 30-Sep-2024).
What was the opening and previous closing prices for AstraZeneca Pharma India Limited?
The stock's performance over the past 52 weeks reveals a low of 4,785.00 (occurred on 14-Mar-2024) and a high of 8,139.00 (achieved on 07-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 4,050.15 (on 21-Mar-2024), and the 52-week high is 8,139.85 (on 30-Sep-2024).
What is the total volume and traded value for AstraZeneca Pharma India Limited for the day?
The total volume is 0, and the total traded value is 3.63 ( Lakhs).
What are the upper and lower circuit limits for AstraZeneca Pharma India Limited?
The upper circuit limit is 8,304.35, and the lower circuit limit is 5,536.25.
What is the market cap and PE ratio for AstraZeneca Pharma India Limited?
The market cap is 171.70 Cr, and the PE ratio (TTM) is 211.19.
What is the PB ratio, industry P/E, and debt to equity ratio for AstraZeneca Pharma India Limited?
The PB ratio is 26.22, industry P/E is 95.94 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for AstraZeneca Pharma India Limited?
ROE is 12.06, EPS is 32.77, book value is 261.99
What are the revenue and profit figures for the latest quarter and previous quarters for AstraZeneca Pharma India Limited?
In Sep 2023, Revenue is 3110716000.00, and Profit is 523698000.00. In Jun 2023, Revenue is 2954668000.00, and Profit is 538607000.00.
When was AstraZeneca Pharma India Limited listed, and what industry does it belong to?
The company, AstraZeneca Pharma India Limited, was listed in May 2001 and belongs to the Pharmaceuticals industry. Its NSE symbol is ASTRAZEN.
What is the current shareholding pattern of the AstraZeneca Pharma India Limited?
As of latest available update, promoters hold 75.00%, the public holds 25.00%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 35
- Threads
- 188
